NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
NeuroOne Medical Technologies (NASDAQ: NMTC), a medical technology company specializing in neurological disorder surgical care solutions, has announced its participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference.
CEO Dave Rosa will deliver a virtual corporate presentation on Wednesday, March 19, 2025, at 9:20 a.m. eastern time. Following the presentation, one-on-one meetings will be available through Oppenheimer. Interested parties can access the live webcast or replay through the provided link or NeuroOne's investor relations website events page.
NeuroOne Medical Technologies (NASDAQ: NMTC), un'azienda di tecnologia medica specializzata in soluzioni per la cura chirurgica dei disturbi neurologici, ha annunciato la sua partecipazione alla 35ª Conferenza Annuale Oppenheimer sulla Salute MedTech & Servizi.
Il CEO Dave Rosa terrà una presentazione aziendale virtuale mercoledì 19 marzo 2025, alle 9:20 ora orientale. Dopo la presentazione, saranno disponibili incontri individuali tramite Oppenheimer. Le parti interessate possono accedere al webcast dal vivo o alla registrazione attraverso il link fornito o la pagina eventi del sito web delle relazioni con gli investitori di NeuroOne.
NeuroOne Medical Technologies (NASDAQ: NMTC), una empresa de tecnología médica especializada en soluciones quirúrgicas para trastornos neurológicos, ha anunciado su participación en la 35ª Conferencia Anual de MedTech y Servicios de Salud de Oppenheimer.
El CEO Dave Rosa realizará una presentación corporativa virtual el miércoles 19 de marzo de 2025, a las 9:20 a.m. hora del este. Tras la presentación, estarán disponibles reuniones individuales a través de Oppenheimer. Las partes interesadas pueden acceder a la transmisión en vivo o a la repetición a través del enlace proporcionado o de la página de eventos del sitio web de relaciones con inversores de NeuroOne.
NeuroOne Medical Technologies (NASDAQ: NMTC), 신경 장애 수술 치료 솔루션을 전문으로 하는 의료 기술 회사가 오펜하이머 제35회 연례 헬스케어 MedTech 및 서비스 컨퍼런스에 참여한다고 발표했습니다.
CEO 데이브 로사는 2025년 3월 19일 수요일, 동부 표준시 오전 9시 20분에 가상 기업 발표를 진행할 예정입니다. 발표 후, 오펜하이머를 통해 일대일 회의가 가능합니다. 관심 있는 분들은 제공된 링크 또는 NeuroOne의 투자자 관계 웹사이트 이벤트 페이지를 통해 생중계 또는 재생을 이용할 수 있습니다.
NeuroOne Medical Technologies (NASDAQ: NMTC), une entreprise de technologie médicale spécialisée dans les solutions chirurgicales pour les troubles neurologiques, a annoncé sa participation à la 35ème Conférence Annuelle Oppenheimer sur la Santé MedTech & Services.
Le PDG Dave Rosa présentera une présentation d'entreprise virtuelle le mercredi 19 mars 2025, à 9h20, heure de l'Est. Après la présentation, des réunions individuelles seront disponibles via Oppenheimer. Les parties intéressées peuvent accéder au webinaire en direct ou à la rediffusion via le lien fourni ou la page événements du site web des relations avec les investisseurs de NeuroOne.
NeuroOne Medical Technologies (NASDAQ: NMTC), ein Medizintechnikunternehmen, das sich auf chirurgische Lösungen für neurologische Störungen spezialisiert hat, hat seine Teilnahme an der 35. jährlichen Healthcare MedTech & Services-Konferenz von Oppenheimer bekannt gegeben.
CEO Dave Rosa wird am Mittwoch, den 19. März 2025, um 9:20 Uhr Eastern Time eine virtuelle Unternehmenspräsentation halten. Nach der Präsentation werden über Oppenheimer persönliche Meetings angeboten. Interessierte Parteien können über den bereitgestellten Link oder die Veranstaltungsseite der Investor Relations-Website von NeuroOne auf das Live-Webcast oder die Wiederholung zugreifen.
- None.
- None.
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that it will participate in the upcoming Oppenheimer 35th Annual Healthcare Conference MedTech & Services Conference on Wednesday, March 19, 2025.
NeuroOne CEO Dave Rosa will host a virtual corporate presentation at 9:20 a.m. eastern time on Wednesday, March 19, 2025, followed by one-on-one meetings, which can be requested through Oppenheimer. To join live or view a replay of the webcast, please visit this link or the events page on NeuroOne’s investors relations website.
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
Chris Donovan
MZ Group – MZ North America
NMTC@mzgroup.us
(914) 352-5853
FAQ
When is NeuroOne (NMTC) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors watch NeuroOne's (NMTC) Oppenheimer Conference presentation?
Will NeuroOne (NMTC) offer one-on-one meetings at the Oppenheimer Conference?
What type of conference is NeuroOne (NMTC) participating in?
